WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017197151) PHOSPHOTIDYLINOSITOL 3-KINASE INHIBITORS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2017/197151    International Application No.:    PCT/US2017/032215
Publication Date: 16.11.2017 International Filing Date: 11.05.2017
IPC:
A61K 31/437 (2006.01), A61K 31/444 (2006.01), A61K 31/4353 (2006.01), C07D 471/00 (2006.01), C07D 471/02 (2006.01), C07D 471/04 (2006.01)
Applicants: EMORY UNIVERSITY [US/US]; Office of Technology Transfer 1599 Clifton Road NE, 4th Floor Atlanta, Georgia 30322 (US)
Inventors: SHI, Qi; (US).
KAISER, Thomas; (US).
DIRADDO, John; (US).
SNYDER, James P.; (US).
LIOTTA, Dennis C.; (US).
DENTMON, Zackery; (US)
Agent: MASON, James C.; (US).
FRITTS, Laura; (US).
ISAACS, Randi; (US).
SHERER, Todd; (US)
Priority Data:
62/334,896 11.05.2016 US
62/478,206 29.03.2017 US
Title (EN) PHOSPHOTIDYLINOSITOL 3-KINASE INHIBITORS
(FR) INHIBITEURS DE PHOSPHOTIDYLINOSITOL 3-KINASES
Abstract: front page image
(EN)This disclosure relates to phosphoinositide 3-kinases (PI3Ks) inhibitors such as N-(5-(imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)sulfonamide derivatives and uses related thereto. In certain embodiments, the disclosure relates to methods of treating PI3K associated diseases or conditions comprising administering an effective amount of a compound disclosed herein to a subject in need thereof. In certain embodiments, the subject is at risk of, exhibiting symptoms of, suffering from, or diagnosed with cancer or a hematological malignancy.
(FR)La présente divulgation concerne des inhibiteurs de phosphoinositide 3-kinases (PI3K) tels que des dérivés de N-(5-(imidazo[1,2-a]pyridin-6-yl)pyridin-3-yl)sulfonamide et leurs utilisations. Dans certains modes de réalisation, la présente divulgation concerne des méthodes de traitement de maladies ou d'états pathologiques associés à PI3K par administration d'une quantité efficace d'un composé ci-décrit à un sujet en ayant besoin. Dans certains modes de réalisation, le sujet est à risque, manifeste des symptômes, souffre, ou a été diagnostiqué comme porteur de cancer ou d'une malignité hématologique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)